Literature DB >> 373076

Antigenic analysis of Mycobacterium leprae.

O Closs, R N Mshana, M Harboe.   

Abstract

About twenty distinct antigenic components have been demonstrated in Mycobacterium leprae (M. leprae) by crossed immunoelectrophoresis against a rabbit antiserum produced by immunization with concentrated M. leprae antigen. This system allows a more detailed analysis of the antigenic relationship between M. leprae and other mycobacteria and a better characterization of the antigenic content of various M leprae preparations than with previously available anstisera of the antigenic content of various M. leprae preparations than with previously available antisera which reacted with far fewer components. The antibody activity in sera of patients with lepromatous leprosy was studied by incorporating the sera into the intermediate gel of the M. leprae reference system. Antibodies were found against only seven of the components. Since those compared are all known to be cross-reacting widely with antigens of other mycobacteria, it is speculated that cross-immunization may influence the antibody response in lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 373076     DOI: 10.1111/j.1365-3083.1979.tb02735.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

Review 1.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

2.  Evaluation of the serological response of sheep in one flock to Mycobacterium paratuberculosis by crossed immunoelectrophoresis.

Authors:  B W Brooks; R H Robertson; A H Corner; B S Samagh; M M Garcia; C Turcotte; J R Duncan
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

3.  Recognition of mycobacterial antigens by sera from patients with leprosy.

Authors:  F Vega-Lopez; N G Stoker; M F Locniskar; H M Dockrell; K A Grant; K P McAdam
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

Review 4.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

5.  Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies.

Authors:  J Ivanyi; S Sinha; R Aston; D Cussell; M Keen; U Sengupta
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

6.  SDS-PAGE analysis of M. leprae protein antigens reacting with antibodies from sera from lepromatous patients and infected armadillos.

Authors:  A K Chakrabarty; M A Maire; P H Lambert
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

7.  Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.

Authors:  R Melsom; M Harboe; B Myrvang; T Godal; A Belehu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera.

Authors:  P R Klatser; M M van Rens; T A Eggelte
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Catalases, peroxidases, and superoxide dismutases in Mycobacterium leprae and other mycobacteria studied by crossed immunoelectrophoresis and polyacrylamide gel electrophoresis.

Authors:  S T Lygren; O Closs; H Bercouvier; L G Wayne
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

10.  Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.

Authors:  W R Levis; H C Meeker; G B Schuller-Levis; T P Gillis; L J Marino; J Zabriskie
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.